Year: 2016
Type: dissertation
Abstract: Environmental factors and lifestyle can alter the way our genes are expressed \ninfluencing a network of chemical switches within our cells collectively known as the \nEpigenome. Among the epigenetic mechanisms orchestrating the gene expression, \nmethylation is of foremost importance and probably fair to say, still incompletely \ndecoded. Dysregulations of histone methylation patterns lead to the repression or \nactivation of signalling pathways that often promote the genesis and progression of \ndisease states. \nLysine specific demethylase 1 (LSD1) oxidatively removes methyl groups from histone \nH3 and its aberrant activity has been correlated with the development of a broad range \nof pathologies. Therefore, specific inhibitors of LSD1 have potential in pharmacological \napplications. Research into LSD1 and its functions in normal and abnormal cells has \nbeen hindered by the lack of a specific and potent suppressor. The development of a \nselective inhibitor could not only foster the understanding of the biological roles of \nLSD1 but also represent a breakthrough for the design of novel drugs for a range of \nburdensome diseases. Here we investigate on reversible and irreversible inhibitors of \nLSD1, with the hope of broadening the current knowledge on this epigenetic target. By \nanalysing the LSD1 interaction with the transcription factor Snail-1, we generated a \nseries of small peptides as potential reversible inhibitors. The synthetic peptides were \nthen evaluated in cellular assays. In search of novel non-covalent LSD1 blockers, we \nnext explored Phage Display technology. Thereafter, we targeted LSD1 covalently by \nsynthesising multiple structural analogues of the clinically used antidepressant TCP \n(Parnate®), which is a known irreversible suppressor of LSD1 activity. We evaluated \ntheir ability of inhibiting LSD1 in a cell-free assay and the compounds showing \nenzymatic inhibition were tested as potential anti-proliferative and differentiating agents \nin leukaemia cell lines. Finally, we generated activity-based probes to fluorescently \nlabel LSD1 for biological applications.
Author: María Teresa Borrello
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2520829914
